Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can move your Mounjaro injection day. Because tirzepatide is a once-weekly medicine, the day you inject is a matter of routine rather than biological timing — the NHS confirms you can shift it by a day or two in either direction, as long as your injections stay at least three days apart. The practical steps matter, though, and your prescriber is the right person to confirm the change suits your current dose and schedule. Mounjaro is a prescription-only medicine that requires clinical oversight throughout treatment, so any lasting change to your routine is worth a quick conversation with the clinician responsible for your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Start by deciding whether you are moving the day earlier or later, and by how much. A one-day shift is the simplest case: if you normally inject on a Tuesday and want to move to a Monday, you simply inject one day ahead at the next opportunity. A shift of two days is equally straightforward in most cases. Bigger moves (say, from Monday to Friday) require a bit more planning, because the three-day gap between injections is not a guideline you can treat loosely. Drop below it and you risk stacking more of the medicine in your system at once, which tends to mean more pronounced side effects rather than better results. The Mounjaro injection guide covers the general injection routine; the day-change question is a layer on top of that.
One practical note: if your next pen is already in the fridge and you are mid-escalation, moving the day can feel more complicated than it is, and our dedicated guide walks through exactly what to consider before you change anything. Map it out before you change anything.
Moving earlier means your next dose comes sooner than the usual seven days) so the gap between this injection and the previous one is shorter, but still needs to clear three full days. Moving later means a slightly longer gap, which is the lower-risk direction. The best day to inject Mounjaro tends to be one you can protect week after week: not the morning the school run starts at 7am, not a Friday evening when you are rushing out the door. Consistency with timing helps your body settle into a predictable rhythm, so pick the new day with that in mind.
If you need to move by four or five days, the safest approach is to creep gradually, shift by one day per week until you reach your target day. That keeps every injection gap comfortably above the minimum without any single bridging dose feeling out of place. Your Patient Information Leaflet spells out the minimum interval; read it alongside this guidance rather than instead of it.
Once the bridging injection is done, that new day becomes day one of your regular weekly cycle. Simple as that. Write it in your phone, set a recurring reminder, note it on the fridge, whatever works. The body does not care whether it is a Wednesday or a Saturday; it cares that the interval is consistent going forward.
Side effects at the time of a dose change are worth monitoring. Nausea, digestive discomfort and fatigue are already the most commonly reported effects on tirzepatide, as the NHS tirzepatide medicines page details, and a slightly shortened gap can make them a little more noticeable for a day or two. That usually settles. If you are still feeling rough after a week, speak to your prescriber rather than guessing at the cause. You can also read more about changing your injection day on Mounjaro and what patients typically experience.
Most minor day shifts (a day or two either way) do not need explicit sign-off, but there are situations where a quick message to your prescribing service makes sense. If you are currently on a higher dose and have had a run of difficult side effects, deliberately shortening an interval adds risk. If you are on tirzepatide alongside other medicines, timing can occasionally interact with absorption windows; your prescriber will know your full picture. And if you are planning a longer trip abroad and want to move your injection day significantly to manage time zones, that is exactly the kind of practical question a good aftercare service should answer quickly.
At nume, our prescribers are available seven days a week for questions like this, part of the same service covered in a single transparent price, with no separate aftercare charge. If you are exploring how private Mounjaro treatment works generally, the weight-loss treatments page explains what the consultation includes. For people weighing up whether private treatment makes financial sense, the weight-loss overview puts the costs in context. And if you have questions about injection technique rather than timing, the injection technique guide covers the practical steps in detail.
One broader point: the fact that Mounjaro allows this flexibility is genuinely useful. Life changes (a new job, a shift pattern, a holiday) and a medicine that locks you into one immovable day every week would be harder to sustain. That adaptability is part of why adherence tends to be higher than with less forgiving regimens, according to the prescribing literature. NICE's appraisal of tirzepatide, TA1026, notes the clinical programme involved thousands of adults, and sustaining treatment over 72 weeks was a key feature of the trial design. Flexibility around the injection day supports that.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.